HR 269 · 116th Congress 2019–2021, ended

Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019

Fact sheet

Latest action · Jan 10, 2019 Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 10.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJan 8, 2019
  2. Passed HouseJan 8, 2019
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019

This bill (1) reauthorizes, revises, and establishes several programs and entities relating to public-health emergency preparedness and response; and (2) addresses the approval process for over-the counter (OTC) drugs.

Among other programs, the bill reauthorizes through FY2023 and revises

  • the Public Health Emergency Preparedness cooperative-agreement program administered by the Centers for Disease Control and Prevention (CDC),
  • the Hospital Preparedness Program,
  • the CDC situational-awareness and biosurveillance program,
  • the Emergency System for Advance Registration of Volunteer Health Professionals,
  • the National Disaster Medical System,
  • the Volunteer Medical Reserve Corps,
  • the National Advisory Committee on Children and Disasters,
  • the Strategic National Stockpile, and
  • the Biomedical Advanced Research and Development Authority.

In addition, the bill provides statutory authority for existing programs, including the CDC's Children's Preparedness Unit and the Public Health Emergency Medical Countermeasures Enterprise. The bill also establishes new programs and entities, including a trauma-center grant program to support military trauma teams.

The bill further modifies the approval process for OTC drugs by providing statutory authority for the Food and Drug Administration (FDA) to (1) regulate certain OTC drugs that are marketed without an approved new-drug application, and (2) issue administrative orders specifying the conditions under which an OTC drug may be deemed safe and effective and not subject to approval as a new drug. The FDA must assess and collect user fees for OTC drugs, including OTC-drug facility and OTC-drug order-request fees.

Recorded votes 1

Newest first. Open one to see how every member voted.

Roll callQuestionResultDate
House 13Passed401–17Jan 8, 2019

Cosponsors 7

Members who signed on, in the order they did. All signed on Jan 8, 2019.

SeatCosponsorSigned on
R-KYBrett GuthrieOriginalJan 8, 2019
D-MIDebbie DingellOriginalJan 8, 2019
D-CODiana DeGetteOriginalJan 8, 2019
D-NJFrank Pallone, Jr.OriginalJan 8, 2019
R-ORGreg WaldenOriginalJan 8, 2019
R-OHRobert E. LattaOriginalJan 8, 2019
R-INSusan W. BrooksOriginalJan 8, 2019

Actions 12

Everything that happened, newest first.

  1. Jan 10, 2019Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 10.
  2. Jan 9, 2019Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
  3. Jan 8, 2019At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
  4. Jan 8, 2019Considered as unfinished business. (consideration: CR H275-276)
  5. Jan 8, 2019Considered under suspension of the rules. (consideration: CR H237-266)

Related bills 5

Companion bills and other measures the record links to this one.

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 2

Each version as it was printed, newest first.

  1. Jan 10, 2019Placed on Calendar Senate
  2. Jan 8, 2019Engrossed in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.